Fufang Shuangjing Quqin Pian (复方双肼屈嗪片)复方双肼屈嗪片

This is a medicine registration record from NMPA data.本页为国家药监局药品注册记录。

Labeled sections from the recorded Chinese source are included below. English wording is a reference translation when one is on file, not an official English label.本记录未接入产品级适应症/安全性标注字段。

生产企业Manufacturer

主要成分Active Ingredients

药物知识说明

双肼屈嗪 氢氯噻嗪 利血平是一种在国家药监局注册认定的药品。该药品含有利血平、双肼屈嗪、氢氯噻嗪-7c628c24等成分。

该药品关联的活性成分包括:利血平Lixue Ping、双肼屈嗪Shuangjing Quqin、氢氯噻嗪Qinglv Saiqin。这些成分信息来自国家药监局数据库。

该药品标注的生产企业为:华润双鹤药业股份有限公司Chinese legal name: 华润双鹤药业股份有限公司。

您可以探索含有相同成分的其他药品:利血平-80d09c1d成分药品。

本页面内容来自国家药监局数据库,MedicineGraph在此基础上提供关系图谱和知识导航。

Medicine Knowledge

This medicine (original name: 复方双肼屈嗪片) is a medicine registered with the national drug regulatory authority. It contains recorded ingredients as active ingredient(s).

Active ingredients associated with this product: 利血平Lixue Ping, 双肼屈嗪Shuangjing Quqin, 氢氯噻嗪Qinglv Saiqin.

Manufacturers recorded for this product: 华润双鹤药业股份有限公司Chinese legal name: 华润双鹤药业股份有限公司.

Explore other medicines containing the same ingredient: 利血平 productsProducts containing this recorded ingredient.

Source: MedicineGraph authoritative database. Relationships derived from registered product information.

这是什么What is this

  • 通用名/品名Recorded product name: 复方双肼屈嗪片Recorded Chinese name: 复方双肼屈嗪片
  • 剂型Dosage form: 片剂Tablets
  • 规格Specification: 硫酸双肼屈嗪10mg,氢氯噻嗪12.5mg,利血平0.1mgRecorded Chinese specification: 硫酸双肼屈嗪10mg,氢氯噻嗪12.5mg,利血平0.1mg

本段仅展示注册/说明书已记录的身份属性,不含适应症或用法建议。Identity attributes from registration/leaflet records only; no indications or usage advice.

主要成分Ingredients

生产企业Manufacturer

  • 华润双鹤药业股份有限公司Chinese legal name: 华润双鹤药业股份有限公司

注册信息NMPA approval number

  • 批准文号NMPA approval number: 国药准字H11021714

信息来源Source and scope

国家药品监督管理局(中国)药品注册数据及已接入说明书字段。National Medical Products Administration (China) medicine-registration data and linked leaflet fields.

  • 品名来源Name source: 10多万条药品说明书数据库 (HIGH)Package-insert database (more than 100,000 records) (HIGH)
  • 生产企业来源Manufacturer source: 10多万条药品说明书数据库Package-insert database (more than 100,000 records)
  • 剂型来源Dosage-form source: 10多万条药品说明书数据库Package-insert database (more than 100,000 records)

范围:当前 MedicineGraph 注册记录及已记录的精确关系;非完整目录,亦不构成疗效等同主张,也不支持换用判断。不含适应症/安全性推断。Scope: current MedicineGraph registration records and exact recorded relationships; not a complete catalog and not a claim of therapeutic equivalence. No inferred indications/safety.

本段为已核准说明书原文摘录(非改写、非AI摘要),非正式英文标签,亦不构成用药建议。 Not an official English label and not medical advice. English wording, when shown, is a reference translation of the Chinese source label.

English translation for reference. Translated from the Chinese source label. Not an official English label and not medical advice.

NMPA approval number

国药准字H11021714

Manufacturer

Chinese legal name: 华润双鹤药业股份有限公司 (domestically manufactured)

Indications

English translation unavailable. The original Chinese source label remains available below.

Dosage and administration

English translation unavailable. The original Chinese source label remains available below.

Adverse reactions

English translation unavailable. The original Chinese source label remains available below.

Contraindications

English translation unavailable. The original Chinese source label remains available below.

Storage

Protect from light and keep tightly closed.

Specification

English translation unavailable. The original Chinese source label remains available below.

中文说明书原文Original Chinese source label

批准文号

国药准字H11021714

生产企业

华润双鹤药业股份有限公司(国产)

适应症

1.周围血管扩张药,松弛血管平滑肌,扩张小动脉,降低周围血管阻力,降低血压,同时增加心排血量,增快心率。 2.降低舒张压较显著,并能增加肾血流量,故多用于肾型高血压及舒张压较高的患者。 3.用于轻、中度高血压。

用法用量

口服:1片/次,2―4次/日。

不良反应

1.常见有心悸、心动过速、头痛、眩晕、恶心、呕吐、食欲减退、体位性低血压、发热等。
2.严重时可引起类风湿性关节炎、红斑性狼疮综合征及水钠潴留现象等。

禁忌

心动过速、冠心病、脑血管硬化及心功能不全患者禁用。

贮藏

遮光,密封保存。

规格

硫酸双肼屈嗪10mg,氢氯噻嗪12.5mg,利血平0.1mg

证据Evidence

  • 批准文号: 国药准字H11021714
  • rights: 本段为已核准说明书原文摘录(非改写、非AI摘要),非正式英文标签,亦不构成用药建议。

信息来源Source and scope

国家药品监督管理局(中国)药品注册数据。National Medical Products Administration (China) medicine-registration data.

范围:当前 MedicineGraph 注册记录及已记录的精确关系;非完整目录,亦不构成疗效等同主张,也不支持换用判断。Scope: current MedicineGraph registration records and exact recorded relationships; not a complete catalog and not a claim of therapeutic equivalence.